Clinical trials recruiting for Castration Resistant Metastatic Prostate Cancer
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Enzalutamide | 1 |
| Metastasis directed radiotherapy | 1 |
| Testosterone cypionate | 1 |
| Testosterone enanthate | 1 |
| [225Ac]Ac-AKY-2519 (therapeutic) | 1 |
| [64Cu]Cu-AKY-2519 (imaging) | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| Nebraska | 2 |
| Florida | 1 |
| Maryland | 1 |
| Massachusetts | 1 |
| Michigan | 1 |
| Minnesota | 1 |
| Washington | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer
- Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
- The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)
Related conditions
Trials recruiting for Castration Resistant Metastatic Prostate Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Castration Resistant Metastatic Prostate Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.